Triple Negative Breast Cancer Clinical Trials
Triple Negative Breast Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for triple Negative Breast Cancer. Corterve aggregates actively recruiting Triple Negative Breast Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Triple Negative Breast Cancer studies
- Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBCNCT07216495NAM.D. Anderson Cancer CenterAerobic ExerciseHouston, Texas
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsNCT06586957PHASE1NiKang Therapeutics, Inc.Solid TumorLittle Rock, Arkansas
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)NCT05579366PHASE1, PHASE2GenmabHigh Grade Epithelial Ovarian CancerPhoenix, Arizona
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsNCT07115043PHASE1, PHASE2AstraZenecaMelanomaGrand Rapids, Michigan
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNCT06465069PHASE1Eli Lilly and CompanyMetastatic Solid TumorDuarte, California
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)NCT04585750PHASE1, PHASE2PMV Pharmaceuticals, IncAdvanced Solid TumorIrvine, California
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsNCT07189871PHASE1, PHASE2Radiopharm Theranostics, LtdCastration-Resistant Prostate Cancer (CRPC)Dothan, Alabama
- PRE-ISPY Phase I/II Oncology Platform ProgramNCT05868226PHASE1, PHASE2QuantumLeap Healthcare CollaborativeHER2-positive Breast CancerBirmingham, Alabama
- First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian CancerNCT06799065PHASE1, PHASE2Accent TherapeuticsAdvanced Solid TumorsAurora, Colorado
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingNCT04981119A2 Biotherapeutics Inc.Solid Tumor, AdultGilbert, Arizona
- Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBCNCT07066189NAYale UniversityTriple Negative Breast CancerNew Haven, Connecticut
- Genomically Guided Radiation Therapy in the Management of Triple Negative Breast CancerNCT05528133PHASE2H. Lee Moffitt Cancer Center and Research InstituteTriple Negative Breast CancerClearwater, Florida
Triple Negative Breast Cancer trials by state
Triple Negative Breast Cancer trials by metro
Frequently asked questions
- How do I find recruiting Triple Negative Breast Cancer clinical trials?
- Browse the actively recruiting Triple Negative Breast Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Triple Negative Breast Cancer clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Triple Negative Breast Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.